Literature DB >> 20881937

Chronic kidney disease aggravates arteriovenous fistula damage in rats.

Stephan Langer1, Maria Kokozidou, Christian Heiss, Jennifer Kranz, Tina Kessler, Niklas Paulus, Thilo Krüger, Michael J Jacobs, Christina Lente, Thomas A Koeppel.   

Abstract

Neointimal hyperplasia (NIH) and impaired dilatation are important contributors to arteriovenous fistula (AVF) failure. It is unclear whether chronic kidney disease (CKD) itself causes adverse remodeling in arterialized veins. Here we determined if CKD specifically triggers adverse effects on vascular remodeling and assessed whether these changes affect the function of AVFs. For this purpose, we used rats on a normal diet or on an adenine-rich diet to induce CKD and created a fistula between the right femoral artery and vein. Fistula maturation was followed noninvasively by high-resolution ultrasound (US), and groups of rats were killed on 42 and 84 days after surgery for histological and immunohistochemical analyses of the AVFs and contralateral femoral vessels. In vivo US and ex vivo morphometric analyses confirmed a significant increase in NIH in the AVFs of both groups with CKD compared to those receiving a normal diet. Furthermore, we found using histological evaluation of the fistula veins in the rats with CKD that the media shrank and their calcification increased significantly. Afferent artery dilatation was significantly impaired in CKD and the downstream fistula vein had delayed dilation after surgery. These changes were accompanied by significantly increased peak systolic velocity at the site of the anastomosis, implying stenosis. Thus, CKD triggers adverse effects on vascular remodeling in AVFs, all of which contribute to anatomical and/or functional stenosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881937     DOI: 10.1038/ki.2010.353

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.

Authors:  Sun Hyung Kwon; Li Li; Yuxia He; Chieh Sheng Tey; Huan Li; Ilya Zhuplatov; Seung-Jung Kim; Christi M Terry; Donald K Blumenthal; Yan-Ting Shiu; Alfred K Cheung
Journal:  J Vasc Res       Date:  2016-01-21       Impact factor: 1.934

2.  Novel paradigms for dialysis vascular access: Introduction.

Authors:  Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2013-12       Impact factor: 8.237

3.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

4.  Caspase-1 Plays a Critical Role in Accelerating Chronic Kidney Disease-Promoted Neointimal Hyperplasia in the Carotid Artery.

Authors:  Lucas M Ferrer; Alexandra M Monroy; Jahaira Lopez-Pastrana; Gayani Nanayakkara; Ramon Cueto; Ya-Feng Li; Xinyuan Li; Hong Wang; Xiao-Feng Yang; Eric T Choi
Journal:  J Cardiovasc Transl Res       Date:  2016-02-29       Impact factor: 4.132

5.  A new arteriovenous fistula model to study the development of neointimal hyperplasia.

Authors:  Eddie Manning; Nikolaos Skartsis; Armando M Orta; Omaida C Velazquez; Zhao-Jun Liu; Arif Asif; Loay H Salman; Roberto I Vazquez-Padron
Journal:  J Vasc Res       Date:  2012-01-13       Impact factor: 1.934

6.  Reduced Expression of Glutathione S-Transferase α 4 Promotes Vascular Neointimal Hyperplasia in CKD.

Authors:  Jinlong Luo; Guang Chen; Ming Liang; Aini Xie; Qingtian Li; Qunying Guo; Rajendra Sharma; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2017-11-10       Impact factor: 10.121

7.  c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae.

Authors:  Nikolaos Skartsis; Laisel Martinez; Juan Camilo Duque; Marwan Tabbara; Omaida C Velazquez; Arif Asif; Fotios Andreopoulos; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-03

8.  Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.

Authors:  Yasuhiro Hashimoto; Kengo Imanishi; Noriko Tokui; Teppei Okamoto; Akiko Okamoto; Shingo Hatakeyama; Takahiro Yoneyama; Takuya Koie; Noritaka Kamimura; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2011-12-27       Impact factor: 3.402

9.  Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD.

Authors:  Yun Wang; Anlin Liang; Jinlong Luo; Ming Liang; Guofeng Han; William E Mitch; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

Review 10.  Vascular access in haemodialysis: strengthening the Achilles' heel.

Authors:  Miguel C Riella; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2013-04-16       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.